Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-14 Sale | 2024-11-18 7:23 pm | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 52,115 | $16.79 | $875,042 | 222,869 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-20 Exercise | 2024-11-21 6:50 pm | N/A 2033-01-15 | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 14,000 | $0 | 116,372 (Direct) | View |
| 2024-11-20 Exercise | 2024-11-21 6:50 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 14,000 | $3.23 | 116,372 (Direct) | View |
| 2024-11-14 Exercise | 2024-11-18 7:23 pm | N/A 2033-01-15 | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 52,115 | $0 | 222,869 (Direct) | View |
| 2024-11-14 Exercise | 2024-11-18 7:23 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 52,115 | $3.23 | 222,869 (Direct) | View |
| 2024-04-08 Exercise | 2024-04-10 9:35 pm | N/A 2033-01-15 | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 146,823 | $0 | 201,752 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 5:08 pm | N/A 2034-01-01 | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 1,776,200 | $0 | 1,776,200 (Direct) | View |
| 2023-11-13 Option Award | 2023-11-15 4:42 pm | N/A 2033-01-15 | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 4,276 | $0 | 4,276 (Direct) | View |